Literature DB >> 16352399

Differential cellular distribution of tonicity-induced expression of transcription factor TonEBP in the rat brain following prolonged systemic hypertonicity.

S Maallem1, M Mutin, H M Kwon, M L Tappaz.   

Abstract

In a previous work performed on cerebral cortex and hippocampus we reported that tonicity-responsive enhancer binding protein (TonEBP), originally identified as a transactivator of osmoprotective genes involved in osmoadaptation of renal cells, was induced in neurons only, but to varying levels, following acute systemic hypertonicity. Whether or not this cellular specificity reflected a unique ability of neurons or a differential time course among brain cells for tonicity-induction of TonEBP was investigated throughout the brain in this study by subjecting the animals to prolonged systemic hypertonicity. In normal rats, TonEBP immunolabeling and TonEBP-mRNA in situ hybridization labeling showed a widespread, uneven and parallel distribution. TonEBP was expressed primarily in the cell nuclei of neurons, where it was heterogeneously distributed in a nucleoplasmic and a granular pool. In rats subjected to prolonged systemic hypertonicity, TonEBP labeling increased in the cell nuclei of neurons only. The tonicity-induced expression of TonEBP for a given cell group of neurons was rather uniform but varied greatly among neuronal cell groups and was positively correlated with the average size of the cell nuclei, as determined by quantitative analysis of digitized images. The detailed distribution of tonicity-induced expression of TonEBP is reported throughout the brain. In normal rats, a very minor proportion of non-neuronal cells, identified as a subset of astrocytes and possibly oligodendrocytes, showed faint nuclear immunolabeling, which however did not increase in hypertonic animals. Ependymocytes, capillary endothelial cells, and microglial cells showed no TonEBP labeling, even in hypertonic animals. Altogether our data indicate that neurons, albeit possibly to a varying extent, are the only brain cells able to use TonEBP-mediated processes for adaptation to a systemic hyperosmotic unbalance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352399     DOI: 10.1016/j.neuroscience.2005.07.037

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Novel nuclear localization signal regulated by ambient tonicity in vertebrates.

Authors:  Min Seong Kwon; Sang Do Lee; Jeong-Ah Kim; Emanuela Colla; Yu Jeong Choi; Pann-Ghil Suh; H Moo Kwon
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

2.  Tonicity-responsive enhancer binding protein haplodeficiency attenuates seizure severity and NF-κB-mediated neuroinflammation in kainic acid-induced seizures.

Authors:  H J Shin; H Kim; R W Heo; H J Kim; W S Choi; H M Kwon; G S Roh
Journal:  Cell Death Differ       Date:  2014-03-07       Impact factor: 15.828

3.  Hippocampal betaine/GABA transporter mRNA expression is not regulated by inflammation or dehydration post-status epilepticus.

Authors:  Nicole M Rowley; Misty D Smith; John G Lamb; Arne Schousboe; H Steve White
Journal:  J Neurochem       Date:  2011-02-09       Impact factor: 5.372

4.  Up-regulation of hypertonicity-activated myo-inositol transporter SMIT1 by the cell volume-sensitive protein kinase SGK1.

Authors:  F Klaus; M Palmada; R Lindner; J Laufer; S Jeyaraj; F Lang; C Boehmer
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

5.  Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle.

Authors:  Erick O Hernández-Ochoa; Patrick Robison; Minerva Contreras; Tiansheng Shen; Zhiyong Zhao; Martin F Schneider
Journal:  Exp Biol Med (Maywood)       Date:  2012-09-10

6.  TonEBP/NFAT5 haploinsufficiency attenuates hippocampal inflammation in high-fat diet/streptozotocin-induced diabetic mice.

Authors:  Jong Youl Lee; Eun Ae Jeong; Kyung Eun Kim; Chin-Ok Yi; Zhen Jin; Jung Eun Lee; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Soo Youn Choi; H Moo Kwon; Gu Seob Roh
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

7.  Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice.

Authors:  Beatriz Morancho; Jordi Minguillón; Jeffery D Molkentin; Cristina López-Rodríguez; Jose Aramburu
Journal:  BMC Mol Biol       Date:  2008-01-25       Impact factor: 2.946

8.  The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress.

Authors:  Katherine Drews-Elger; M Carmen Ortells; Anjana Rao; Cristina López-Rodriguez; Jose Aramburu
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

9.  Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence.

Authors:  N Fernàndez-Castillo; J Cabana-Domínguez; J Soriano; C Sànchez-Mora; C Roncero; L Grau-López; E Ros-Cucurull; C Daigre; M M J van Donkelaar; B Franke; M Casas; M Ribasés; B Cormand
Journal:  Transl Psychiatry       Date:  2015-10-27       Impact factor: 6.222

10.  Transcription Factor TonEBP Stimulates Hyperosmolality-Dependent Arginine Vasopressin Gene Expression in the Mouse Hypothalamus.

Authors:  Dong Hee Kim; Kwang Kon Kim; Tae Hwan Lee; Hyejin Eom; Jin Woo Kim; Jeong Woo Park; Jin Kwon Jeong; Byung Ju Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.